Abstract
Derivation of insulin producing cells (IPCs) from embryonic stem (ES) cells provides a potentially innovative form of treatment for type 1 diabetes. Here, we discuss the current state of the art, unique challenges, and future directions on generating IPCs.
(c) 2008 Wiley-Liss, Inc.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Review
MeSH terms
-
Animals
-
Cell Differentiation
-
Embryonic Stem Cells / cytology*
-
Endoderm / cytology
-
Humans
-
Insulin-Secreting Cells / cytology*
-
Insulin-Secreting Cells / transplantation
-
Organ Specificity
-
Transcription Factors / metabolism